Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2007 1
2009 2
2011 2
2012 1
2013 1
2016 2
2017 1
2018 1
2020 1
2021 1
2022 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Renal Involvement in Antiphospholipid Syndrome.
Turrent-Carriles A, Herrera-Félix JP, Amigo MC. Turrent-Carriles A, et al. Front Immunol. 2018 May 17;9:1008. doi: 10.3389/fimmu.2018.01008. eCollection 2018. Front Immunol. 2018. PMID: 29867982 Free PMC article. Review.
Antiphospholipid syndrome nephropathy can also complicate patients with systemic lupus erythematosus, and there is vast information supporting the worse renal prognosis in this group of patients with the classic histopathologic lesions. ...
Antiphospholipid syndrome nephropathy can also complicate patients with systemic lupus erythematosus, and there is vast information supporti …
Stroke Mechanism in COVID-19 Infection: A Prospective Case-Control Study.
Topcuoglu MA, Pektezel MY, Oge DD, Bulut Yüksel ND, Ayvacioglu C, Demirel E, Balci S, Arat A, Akinci SB, Arsava EM. Topcuoglu MA, et al. J Stroke Cerebrovasc Dis. 2021 Aug;30(8):105919. doi: 10.1016/j.jstrokecerebrovasdis.2021.105919. Epub 2021 Jun 1. J Stroke Cerebrovasc Dis. 2021. PMID: 34130106 Free PMC article.
Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity.
Yelnik CM, Urbanski G, Drumez E, Sobanski V, Maillard H, Lanteri A, Morell-Dubois S, Caron C, Dubucquoi S, Launay D, Duhamel A, Hachulla E, Hatron PY, Lambert M. Yelnik CM, et al. Lupus. 2017 Feb;26(2):163-169. doi: 10.1177/0961203316657433. Epub 2016 Jul 20. Lupus. 2017. PMID: 27432808
The annual first thrombosis rate was 2.3% per patient-year during a median of 13 years (6-17). None of the baseline characteristics was predictive of risk of first thrombosis, but persistent aPL over time were associated with an increased risk. ...
The annual first thrombosis rate was 2.3% per patient-year during a median of 13 years (6-17). None of the baseline characteristics was p …
Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study.
de Frémont GM, Costedoat-Chalumeau N, Lazaro E, Belkhir R, Guettrot-Imbert G, Morel N, Nocturne G, Molto A, Goulenok T, Diot E, Perard L, Ferreira-Maldent N, Le Besnerais M, Limal N, Martis N, Abisror N, Debouverie O, Richez C, Sobanski V, Maurier F, Sauvetre G, Levesque H, Timsit MA, Tieulié N, Orquevaux P, Bienvenu B, Mahevas M, Papo T, Lartigau-Roussin C, Chauvet E, Berthoux E, Sarrot-Reynauld F, Raffray L, Couderc M, Silva NM, Jourde-Chiche N, Belhomme N, Thomas T, Poindron V, Queyrel-Moranne V, Delforge J, Le Ray C, Pannier E, Mariette X, Le Guern V, Seror R; GR2 Study Group. de Frémont GM, et al. Lancet Rheumatol. 2023 Jun;5(6):e330-e340. doi: 10.1016/S2665-9913(23)00099-1. Epub 2023 May 8. Lancet Rheumatol. 2023. PMID: 38251600
We aimed to describe adverse pregnancy, delivery, and birth outcome risks in pregnant women with primary Sjogren's syndrome compared with those of a matched general population in France, and to identify factors predictive of disease flares or adverse pregnancy outcomes. ME …
We aimed to describe adverse pregnancy, delivery, and birth outcome risks in pregnant women with primary Sjogren's syndrome compared with th …
Factors associated with adverse pregnancy outcomes in patients with systemic lupus erythematosus.
Sieiro Santos C, Moriano Morales C, Álvarez Castro C, González Fernández I, Díez Álvarez E. Sieiro Santos C, et al. Musculoskeletal Care. 2022 Dec;20(4):917-925. doi: 10.1002/msc.1658. Epub 2022 May 26. Musculoskeletal Care. 2022. PMID: 35615936
BACKGROUND: Pregnancies in Systemic lupus erythematosus (SLE) are considered high risk and associated with maternal and obstetric complications. OBJECTIVES: To determine the most important predictors for each of the main adverse pregnancy outcomes in SLE patients. ...Multi …
BACKGROUND: Pregnancies in Systemic lupus erythematosus (SLE) are considered high risk and associated with maternal and obstetric complicati …
Lipid management in systemic lupus erythematosus according to risk classifiers suggested by the European Society of Cardiology and disease-related risk factors reported by the EULAR recommendations.
Drosos GC, Konstantonis G, Sfikakis PP, Tektonidou MG. Drosos GC, et al. RMD Open. 2023 Feb;9(1):e002767. doi: 10.1136/rmdopen-2022-002767. RMD Open. 2023. PMID: 36759009 Free PMC article.
Atherosclerotic plaques on carotid ultrasound (cUS)) and carotid and femoral ultrasound (cfUS), prolonged disease duration (PDD, 10 years), failure to achieve lupus low disease activity state (LLDAS(no)), cumulative glucocorticoid 'cardiovascular harm' dose (GC(CVH), optimal cut- …
Atherosclerotic plaques on carotid ultrasound (cUS)) and carotid and femoral ultrasound (cfUS), prolonged disease duration (PDD, 10 years), …
Maternal and fetal outcomes of lupus pregnancies: A collective effort by Karnataka Rheumatologists.
Janardana R, Haridas V, Priya V, Bhat V, Singh Y, Rao VK, Jois R, Srikantiah C, Pinto B, Shobha V. Janardana R, et al. Lupus. 2020 Oct;29(11):1397-1403. doi: 10.1177/0961203320944503. Epub 2020 Aug 2. Lupus. 2020. PMID: 32741300
INTRODUCTION: Identifying factors predicting adverse pregnancy outcomes involving systemic lupus erythematosus (SLE) is a research priority. ...
INTRODUCTION: Identifying factors predicting adverse pregnancy outcomes involving systemic lupus erythematosus (SLE) is a research pr …
Lipid peroxidation as risk factor for endothelial dysfunction in antiphospholipid syndrome patients.
Stanisavljevic N, Stojanovich L, Marisavljevic D, Djokovic A, Dopsaj V, Kotur-Stevuljevic J, Martinovic J, Memon L, Radovanovic S, Todic B, Lisulov D. Stanisavljevic N, et al. Clin Rheumatol. 2016 Oct;35(10):2485-93. doi: 10.1007/s10067-016-3369-8. Epub 2016 Aug 25. Clin Rheumatol. 2016. PMID: 27562033
Cholesterol is independent variable for FMD impairment in control group (p = 0.011); LOOH in PAPS (p = 0.004); LOOH, aCL, and triglycerides in SAPS patients (p = 0.009, p = 0.049, and p = 0.012, respectively). Combined predictive of aCL and LOOH is better for FMD impairmen …
Cholesterol is independent variable for FMD impairment in control group (p = 0.011); LOOH in PAPS (p = 0.004); LOOH, aCL, and triglycerides …
16 results